HU891461D0 - Process for the preparation of novel compounds - Google Patents

Process for the preparation of novel compounds

Info

Publication number
HU891461D0
HU891461D0 HU891461A HU146189A HU891461D0 HU 891461 D0 HU891461 D0 HU 891461D0 HU 891461 A HU891461 A HU 891461A HU 146189 A HU146189 A HU 146189A HU 891461 D0 HU891461 D0 HU 891461D0
Authority
HU
Hungary
Prior art keywords
preparation
novel compounds
novel
compounds
Prior art date
Application number
HU891461A
Other languages
English (en)
Inventor
Robert John Ife
Original Assignee
Smithkline Beckman Intercredit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Intercredit filed Critical Smithkline Beckman Intercredit
Publication of HU891461D0 publication Critical patent/HU891461D0/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
HU891461A 1988-02-25 1989-02-20 Process for the preparation of novel compounds HU891461D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888804448A GB8804448D0 (en) 1988-02-25 1988-02-25 Compounds

Publications (1)

Publication Number Publication Date
HU891461D0 true HU891461D0 (en) 1990-01-28

Family

ID=10632380

Family Applications (1)

Application Number Title Priority Date Filing Date
HU891461A HU891461D0 (en) 1988-02-25 1989-02-20 Process for the preparation of novel compounds

Country Status (16)

Country Link
US (1) US4935431A (hu)
EP (1) EP0334491A1 (hu)
JP (1) JPH02503317A (hu)
KR (1) KR900700485A (hu)
CN (1) CN1035508A (hu)
AU (1) AU3181689A (hu)
DK (1) DK528689A (hu)
FI (1) FI895047A0 (hu)
GB (1) GB8804448D0 (hu)
HU (1) HU891461D0 (hu)
IL (1) IL89347A0 (hu)
NO (1) NO894228L (hu)
PT (1) PT89793A (hu)
WO (1) WO1989008112A1 (hu)
ZA (1) ZA891440B (hu)
ZW (1) ZW2089A1 (hu)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
US5026700A (en) * 1989-05-16 1991-06-25 Merrell Dow Pharmaceuticals Certain quinolines and thienopyridines as excitatory amino acid antagonists
AU626418B2 (en) * 1989-05-16 1992-07-30 Merrell Pharmaceuticals Inc. Excitatory amino acid antagonists
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
IE68593B1 (en) * 1989-12-06 1996-06-26 Sanofi Sa Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
GB9010296D0 (en) * 1990-05-08 1990-06-27 Beecham Group Plc Novel compounds
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
KR0169813B1 (ko) * 1995-07-12 1999-01-15 김종인 4-아미노-3-아실나프티리딘 유도체
US6103903A (en) 1998-02-26 2000-08-15 Neurogen Corporation 4-(4-piperidylmethyhlamino) substituted heteroaryl fused pyridines: GABA brain receptor ligands
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
AU2005315937A1 (en) 2004-12-17 2006-06-22 F. Hoffmann-La Roche Ag Thieno-pyridine derivatives as GABA-B allosteric enhancers
JP2008542328A (ja) 2005-06-02 2008-11-27 エフ.ホフマン−ラ ロシュ アーゲー Gaba−bエンハンサーとしての3−メタンスルホニルキノリン
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
ES2356032T3 (es) 2007-09-14 2011-04-04 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 4-fenil-3,4,5,6-tetrahidro-2h,1'h-[1,4']bipiridinil-2'-onas 1,3'-disustituidas.
TW200922566A (en) 2007-09-14 2009-06-01 Ortho Mcneil Janssen Pharm 1,3 disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
EA016969B1 (ru) 2007-09-14 2012-08-30 Аддекс Фарма С.А. 1,3-двузамещенные-4-фенил-1н-пиридин-2-оны
US8785486B2 (en) 2007-11-14 2014-07-22 Janssen Pharmaceuticals, Inc. Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
WO2009062288A1 (en) * 2007-11-15 2009-05-22 Boehringer Ingelheim International Gmbh Inhibitors of human immunodeficiency virus replication
MX2011002042A (es) 2008-09-02 2011-06-20 Ortho Mcneil Janssen Pharm Derivados de 3-azabiciclo[3.1.o]hexilo como moduladores de los receptores del glutamato metabotropico.
MX2011003691A (es) 2008-10-16 2011-09-06 Ortho Mcneil Janssen Pharm Derivados de indol y benzomorfolina como moduladores de los receptores de glutamato metabotropico.
EP2373649B1 (en) 2008-11-28 2013-01-23 Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MX2011011964A (es) 2009-05-12 2012-02-23 Janssen Pharmaceuticals Inc Derivados de 1,2,3-triazolo[4,3-a]piridina y su uso para el tratamiento o prevencion de trastornos neurologicos y psiquiatricos.
NZ596053A (en) 2009-05-12 2013-05-31 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JP5852666B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
US9012448B2 (en) 2010-11-08 2015-04-21 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
EP2649069B1 (en) 2010-11-08 2015-08-26 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
KR102414246B1 (ko) 2014-01-21 2022-06-27 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
LT3431106T (lt) 2014-01-21 2021-02-10 Janssen Pharmaceutica Nv Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2652398A (en) * 1949-11-17 1953-09-15 Endo Products Inc N-substituted-2-amino (methyl) quinolines
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
CA942748A (en) * 1970-09-18 1974-02-26 Venkatachala L. Narayanan 1-aziridinylcarbonyl substituted-3-quinolinecarboxylic acid compounds
US4343804A (en) * 1979-03-26 1982-08-10 A. H. Robins Company, Inc. 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
EP0126970A3 (en) * 1983-04-27 1985-11-06 Beecham Group Plc Anxiolytic and anti-depressant thienopyridine derivatives
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds

Also Published As

Publication number Publication date
NO894228D0 (no) 1989-10-24
DK528689D0 (da) 1989-10-24
IL89347A0 (en) 1989-12-15
US4935431A (en) 1990-06-19
JPH02503317A (ja) 1990-10-11
GB8804448D0 (en) 1988-03-23
EP0334491A1 (en) 1989-09-27
ZW2089A1 (en) 1989-09-13
ZA891440B (en) 1990-10-31
NO894228L (no) 1989-10-24
PT89793A (pt) 1989-10-04
KR900700485A (ko) 1990-08-13
DK528689A (da) 1989-10-24
WO1989008112A1 (en) 1989-09-08
AU3181689A (en) 1989-09-22
FI895047A0 (fi) 1989-10-24
CN1035508A (zh) 1989-09-13

Similar Documents

Publication Publication Date Title
HU891461D0 (en) Process for the preparation of novel compounds
PT86309A (en) Process for the preparation of substituted basic 2-aminotetralins
EP0428003A3 (en) Process for the preparation of polyetherglycols
HU891463D0 (en) Process for the preparation of novel compounds
HU895848D0 (en) Process for the preparation of fluoxethyne analogs
HU901593D0 (en) Process for the preparation of novel compounds
BG51041A3 (en) Process for the preparation of (s)- alpha- ethyl- 2- oxo- 1- pyrrolidineacetamide
HU895849D0 (en) Process for the preparation of 1-threonine
HU896472D0 (en) Process for the preparation of novel benzopyramylpyrrolinone derivatives
EP0365970A3 (en) Process for the preparation of cyclopropanamide
PT84268A (en) Process for the preparation of cyanoethanimidamide compounds
ZA902149B (en) Process for the preparation of o-carboxypyridyl-and o-carboxyquinolylimidazolinones
HU895262D0 (en) Improved process for the preparation of phenfluramine
IL93596A0 (en) Process for the preparation of n-allylmetatrifluoromethyl-aniline
HU901603D0 (en) Process for the preparation of fluoro-phenols
GB2217707B (en) Process for the preparation of acryloyloxyethoxymethyl-melamines
EP0324336A3 (en) Process for the preparation of 3-cyano-4-aryl-pyrroles
EP0412361A3 (en) Process for the preparation of 4-methylentetrahydropyran
EP0415189A3 (en) Process for the preparation of aminbenzylalcohol
IL95496A0 (en) Process for the preparation of fluoropyridines
GB2224026B (en) Process for the preparation of 3-phenoxybenzylalcohol
ZA909346B (en) Process for the preparation of alkylene-bis(2-pyridylamine)compounds
GB2236535B (en) Process for the preparation of nu-substituted nitro-p-phenylenediamines
EP0437820A3 (en) Process for the preparation of glycosyl-anthracyclinones
IL90302A0 (en) Process for the preparation of 2-alkylpyrimidines